Back
Cognition Therapeutics Stock Price Chart
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
7
CGTX
Cognition Therapeutics
Last Price:
$0.39
Seasonality Move:
1.72%
7 Day Trial
ALL ACCESS PASS
$
7
Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CGTX is experiencing slight buying pressure.
Cognition Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.42 | Sell |
| 20-day SMA: | 0.43 | Sell |
| 50-day SMA: | 0.53 | Sell |
| 200-day SMA: | 0.75 | Sell |
| 8-day EMA: | 0.42 | Sell |
| 20-day EMA: | 0.44 | Sell |
| 50-day EMA: | 0.5 | Sell |
| 200-day EMA: | 0.8 | Sell |
Cognition Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 36.45 | Sell |
| Chaikin Money Flow: | -249484 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.41 - 0.45) | Sell |
| Bollinger Bands (100): | (0.41 - 0.69) | Sell |
Cognition Therapeutics Technical Analysis
| Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cognition Therapeutics Stock
Is Cognition Therapeutics Stock a Buy?
-
Cognition Therapeutics share price is 0.39 while CGTX 8-day simple moving average is 0.42, which is a Sell signal.
-
The stock price of CGTX is 0.39 while Cognition Therapeutics 20-day SMA is 0.43, which makes it a Sell.
-
Cognition Therapeutics 50-day simple moving average is 0.53 while CGTX share price is 0.39, making it a Sell technically.
-
CGTX stock price is 0.39 and Cognition Therapeutics 200-day simple moving average is 0.75, creating a Sell signal.
CGTX Technical Analysis vs Fundamental Analysis
Sell
7
Cognition Therapeutics (CGTX)
is a Sell
Is Cognition Therapeutics a Buy or a Sell?
-
Cognition Therapeutics stock is rated a SellThe current Cognition Therapeutics [CGTX] share price is $0.39. The Score for CGTX is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
Cognition Therapeutics Stock Info
Market Cap:
23.9M
Price in USD:
0.39
Share Volume:
466.4K
Cognition Therapeutics 52-Week Range
52-Week High:
2.95
52-Week Low:
0.34
Sell
7
Cognition Therapeutics (CGTX)
is a Sell
Cognition Therapeutics Share Price Forecast
-
What is the Cognition Therapeutics stock price today?The Cognition Therapeutics stock price is 0.39 USD today.
-
Will CGTX stock go up or go down?Cognition Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cognition Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cognition Therapeutics is overvalued.
Is Cognition Therapeutics Stock a Buy?
-
Cognition Therapeutics share price is 0.39 while CGTX 8-day exponential moving average is 0.42, which is a Sell signal.
-
The stock price of CGTX is 0.39 while Cognition Therapeutics 20-day EMA is 0.44, which makes it a Sell.
-
Cognition Therapeutics 50-day exponential moving average is 0.50 while CGTX share price is 0.39, making it a Sell technically.
-
CGTX stock price is 0.39 and Cognition Therapeutics 200-day simple moving average is 0.80, creating a Sell signal.
Fundamental Analysis of Cognition Therapeutics
Is Cognition Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.02 per share, an increase this year of $0.39 per share, and an increase next year of $0.14 per share.
Technical Analysis of Cognition Therapeutics
Should I short Cognition Therapeutics stock?
-
CGTX Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Cognition Therapeutics is a Sell
-
Cognition Therapeutics Relative Strength Index (RSI) is 36.45, which suggest Cognition Therapeutics is oversold
-
The Bollinger Bands (25) for Cognition Therapeutics is (0.41 - 0.45), which suggest Cognition Therapeutics is a Sell
-
The Bollinger Bands (100) for Cognition Therapeutics is (0.41 - 0.69), which suggest Cognition Therapeutics is a Sell
* Cognition Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.